New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler is licensed for the treatment of asthma where use of a combination product is appropriate.

by Lisa Lytle
Patients should not be initiated on Aloflute during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma. | CAVALLINI JAMES/SCIENCE PHOTO LIBRARY
Patients should not be initiated on Aloflute during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma. | CAVALLINI JAMES/SCIENCE PHOTO LIBRARY

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package